# Single Ascending Dose Study of MYK-461 in Healthy Volunteers

> **NCT02356289** · PHASE1 · COMPLETED · sponsor: **MyoKardia, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** MYK-461

## Key facts

- **NCT ID:** NCT02356289
- **Lead sponsor:** MyoKardia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356289, "Single Ascending Dose Study of MYK-461 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02356289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*